论文部分内容阅读
Background and Objection Autologus hematopoietic stem cell transplantation (auto-HSCT) has now been widely used in treatment of malignant hematopathy,some solid tumor,and autoimmune diseases and so on.Engraftment failure (EF) is a severe complication after auto-HSCT,and is occurring in 2 %to 9.5 %of patients.